Your patch management strategy may need an overhaul, as flaw exploitation significantly outpaces credential abuse as the ...

In June 2020, Intel announced the first hardware availability of Control-Flow Enforcement Technology (CET). This ...

Opus Genetics Virtual R&D Science Forum Scheduled for Tuesday, June 16, 2026, at 10:00 am ETUpcoming Data Readout for Cohort 1 of OPGx-BEST1 ...

None ...

As cyber threats grow faster and more destructive, the top cyber insurance companies in the USA distinguish themselves with ...

Product Revenue -- $0.4 million, decreased from $0.8 million, reflecting limited commercial activity and ongoing investment ...

The 33 companies that made it to this year's Best Fintechs to Work For list are actively preserving remote work options and ...

The recent approval of Regeneron’s Otarmeni underscores the maturation of gene therapies across a range of diseases. Here, ...

Opus Genetics, Inc. (Nasdaq: IRD) (“Opus Genetics” or the “Company”), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients with ...

Investigational New Drug application for KHN921 received 'study may proceed” from the US FDA. KHN921 is a potential 'first-in-class' cardiovascular AAV gene therapy being developed for the treatment o ...

Essent Guaranty’s mortgage insurance provision for losses increased to $37.6 million in the first quarter of 2026, up from ...

Issued on behalf of Rua Gold Inc.A 100%-owned underground gold-antimony starter mine in the historic Reefton Goldfield, with a positive PEA ...